[Hepatitis C--clinical aspects, diagnosis and therapy].
Hepatitis C is caused by a flavivirus measuring 30 to 60 nm in diameter which in Germany has an incidence of 0.4 to 0.7% among the general population. Transmission is largely hematogenous and high-risk groups include needle-using drug addicts, hemophiliacs, and patients on dialysis. The diagnosis is based on the detection of hepatitis C antibodies, HCV-RNS PCR and histological findings. The symptoms are mild and the chronification rate may by as high as 80%. The treatment of choice is alpha interferon.
Mörl
M
M
II, Medizinische Klinik (Gastroenterologie, Hepatologie, Endokrinologie), Krankenhaus Am Bürgerpark, Bremerhaven.
D006526:Hepatitis C / Q000175:diagnosis* / Q000628:therapy / Q000635:transmission; D006521:Hepatitis, Chronic / Q000628:therapy; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D011379:Prognosis
D016898:Interferon-alpha
Hepatitis C--Klinik, Diagnose und Therapie.